.png)

Growth equity investors may pass on a Series B deal when revenue is concentrated, ARR includes non-recurring fees, gross margins lag SaaS benchmarks, or ACV is declining. Before outreach, founders should rebuild revenue metrics from contracts and examine concentration, margins, and ACV cohorts over time.
Revenue quality is the first filter growth equity investors apply at Series B. Before a lead investor models your valuation, evaluates your growth rate, or assesses your team, they run a revenue quality screen. Four specific problems end deals at this stage: customer concentration risk, non-recurring revenue inflating ARR, gross margins below institutional thresholds, and contracting average contract value trends. Each one signals a different kind of structural fragility. Together, they tell an investor that the revenue number on your cover slide does not mean what it appears to mean.
According to ICONIQ Growth's published benchmarking data, net dollar retention for institutional-grade B2B software companies has stabilized in the 110% to 120% range as of 2025, with early-stage companies showing the strongest retention performance in the dataset. Companies that fall below those thresholds at the time of raise face a materially harder process. The benchmark exists because investors use it as a proxy for revenue quality before they open a financial model.
The Capital Raise Pre-Flight is IRC Partners' fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership.
Understanding how growth equity investors evaluate a Series B company gives founders the full picture of the evaluation framework. Revenue quality is the gate that determines whether the rest of that evaluation even begins.
The four revenue quality red flags covered in this article:
Customer concentration is one of the fastest deal-killers at Series B because it converts ARR from a durable asset into a single-point-of-failure risk. Growth equity investors underwrite SaaS businesses on the assumption that revenue is repeatable and distributed. A single customer representing 20% or more of ARR breaks that assumption.
Growth equity investors treat customer concentration as a primary diligence flag at the Series B stage. The standard institutional threshold is 20% of ARR from a single customer, which triggers required explanation and mitigation before a round can be priced. At 30% or above, the issue moves from a flag to a frequent deal-stopper, based on the diligence standards documented across Bessemer Venture Partners' State of the Cloud research and the broader growth equity market.
The concern is straightforward. If that customer churns, renews at a lower value, or renegotiates terms, the company's reported ARR drops materially. A company reporting $15M ARR with one customer at $3.5M is reporting a number that is one renewal conversation away from a 23% reduction. Investors writing growth equity checks at the Series B stage do not take that risk on faith.
Reducing concentration takes time, which is why founders need to identify this problem 12 to 18 months before a planned raise. The fix involves two parallel tracks: accelerating new customer acquisition in the $50K to $150K ACV range to dilute the concentration percentage, and securing multi-year contract extensions with the concentrated customer to reduce churn risk during the raise window. Investors will still flag the concentration, but a signed three-year renewal with a concentrated customer converts an existential risk into a manageable one.
ARR is supposed to measure the annualized value of recurring, contracted revenue. When professional services fees, implementation charges, one-time setup fees, or variable usage revenue get included in the ARR figure, the number becomes unreliable as a predictor of future revenue. Growth equity investors build their valuation models on ARR. If the ARR is contaminated, the model is wrong.
Growth equity investors who rebuild ARR from contracts during diligence consistently strip professional services, one-time fees, and non-contracted usage revenue from the reported figure. Companies whose investor-calculated ARR differs materially from their reported ARR face longer diligence timelines and credibility questions across the rest of the data room.
The categories investors strip out when they rebuild ARR from scratch:
The damage from non-recurring revenue in ARR extends beyond the top-line number. It inflates the ARR growth rate, understates churn (because non-recurring revenue that does not repeat looks like a renewal that did not happen), and distorts net revenue retention. A company with $18M in reported ARR that includes $2.5M in professional services is presenting a $15.5M ARR business with a services revenue line that investors will value at a much lower multiple.
The fix: Rebuild your ARR schedule from contracts before going to market. Separate subscription ARR, professional services revenue, and variable usage into distinct line items. Present the ARR number that matches what a growth equity investor will calculate when they do the same exercise. Arriving at the same number they would arrive at builds credibility. Arriving at a different number raises questions about everything else.
Gross margin is the metric growth equity investors use to evaluate whether a SaaS business is structurally capable of generating the returns that justify a growth equity check. A company growing at 80% year-over-year with 55% gross margins is a fundamentally different investment than the same company with 78% gross margins. The valuation multiple, the capital efficiency story, and the path to profitability all change. Founders who want to understand how gross margin feeds directly into the valuation model should review how startup valuation works at the growth stage before going to market.
At Series A, investors are primarily funding growth. At Series B, they are funding a business model. The distinction matters because a business with low gross margins requires more capital to reach the same profitability milestone as a high-margin business. Growth equity investors model exit multiples on ARR, but they also model the capital required to get there. A company with 58% gross margins needs more of that capital to reach breakeven, which compresses the return on the growth equity check.
Several structural issues drive gross margins below 70% in B2B SaaS companies at the $10M to $30M ARR stage:
Founders with gross margins below 70% have two options. The first is structural improvement: audit hosting costs, renegotiate vendor contracts, and reduce the services component of COGS before going to market. The second is transparent framing: present a gross margin bridge that shows the current margin, the drivers of the gap, and a credible path to 70%+ within 12 to 18 months post-raise. Investors can work with a margin improvement story. They struggle with a margin problem that has no explanation.
Average contract value trends are a leading indicator of pricing power, product positioning, and customer mix trajectory. When ACV is declining over time, it tells a growth equity investor one of three things: the company is moving downmarket, customers are negotiating harder at renewal, or the product is losing differentiation against alternatives. All three interpretations raise the same concern: the revenue being generated today is worth less per customer than the revenue generated 18 months ago.
KeyBanc Capital Markets' SaaS survey tracks median ACV across more than 100 private SaaS companies annually. Their 2024 survey data shows a median ACV of $62,000 across the private B2B SaaS market, up from $56,000 in 2023 and $54,000 in 2022, reflecting an upmarket shift as companies pursue larger customers. A declining ACV trend in that range signals that the company is closing more deals at lower prices, which means more customers are needed to maintain the same ARR growth rate.
Growth equity investors look at ACV trend over six to eight quarters. The current number alone tells them nothing about direction. A company with a $40K median ACV today that sat at $52K two years ago is, as an example, a different business than one that has held $40K consistently. The declining trend raises questions that the current ACV alone does not:
{{main-cta}}
The correction for contracting ACV depends on the cause. If the issue is discounting, the fix is a pricing discipline audit and a cohort analysis that shows renewal rates and expansion revenue by original deal price. If the issue is customer mix, the fix is a segmentation analysis that separates SMB, mid-market, and enterprise ACV trends and shows the company's intentional focus on the higher-value segment. If the issue is product differentiation, the fix requires product investment before the raise, which is why identifying this problem early matters.
What investors want to see instead of a declining ACV trend:
Founders preparing for a Series B should pull their ACV cohort data and trend it before any investor conversation. If the math is messy, common mistakes companies make in capital raising often show up first in the revenue story, not the pitch deck.
The four issues covered here, concentration risk, ARR contamination, weak gross margins, and contracting ACV, each have a fix. The problem is that the fix requires time. Founders who identify these issues six to twelve months before a planned raise have room to correct them. Founders who find them during diligence do not.
A pre-raise revenue quality audit covers four steps:
Founders who complete this audit before going to market arrive at investor conversations with the same numbers investors will calculate. That alignment builds credibility and compresses diligence timelines.
The institutional benchmark, according to OpenView Partners' SaaS benchmarks report, is 70% to 80% gross margin for B2B SaaS companies at the growth equity stage. Top-quartile companies operate above 80%. Companies below 70% face valuation pressure and additional diligence questions about cost structure, services mix, and the path to margin improvement. A gross margin below 60% is a structural concern that most growth equity investors will require a detailed explanation for before proceeding.
When growth equity investors rebuild ARR from contracts during diligence, they include only contracted, recurring subscription revenue. Professional services fees, implementation charges, one-time setup costs, and variable usage revenue above contracted minimums are excluded. The resulting number is often materially lower than what founders presented on the cover slide. That gap creates credibility pressure across every other metric in the data room, because investors begin questioning what else was measured inconsistently.
The standard institutional threshold is 20% of ARR from a single customer. At that level, growth equity investors require explicit explanation and a mitigation plan before a round can be priced. At 30% or above, the issue frequently becomes a deal-stopper. Growth equity investors underwrite SaaS revenue as distributed and repeatable. A single customer at 25% of ARR represents a churn event that could reduce reported ARR by a quarter overnight.
A declining average contract value trend over six to eight quarters signals one of three things to a growth equity investor: the sales team is discounting to hit quota, the company has drifted downmarket toward lower-value customers, or the product is losing competitive differentiation and buyers are negotiating harder at renewal. All three interpretations raise concerns about pricing power and the durability of future revenue. KeyBanc Capital Markets' 2024 SaaS survey data shows the private B2B SaaS market median ACV at $62,000, up from $54,000 in 2022, with the trend driven by companies moving upmarket toward larger customers.
Twelve to eighteen months before planned outreach. That window allows time to identify concentration issues and execute new customer acquisition campaigns to dilute them, rebuild the ARR schedule from contracts and correct any non-recurring items, address gross margin gaps through infrastructure optimization or vendor renegotiation, and prepare a credible ACV cohort analysis. Founders who begin this process after investor conversations have started are managing the problem under diligence pressure, which almost always produces worse outcomes.
When professional services revenue grows inside ARR, investors strip it out and apply a lower multiple to it. Services revenue carries a different margin profile and lower predictability than subscription ARR. A material services component also tells investors the product depends on heavy human effort to deploy, which is a scalability concern at the $10M to $30M ARR stage.
Gross revenue retention measures how much of last year's ARR was retained in the current year, excluding any expansion revenue. It captures pure churn and downgrades. Net revenue retention includes expansion revenue from upsells and cross-sells. ICONIQ Growth's published benchmarking data shows net dollar retention for institutional-grade B2B software companies settling in the 110% to 120% range in 2025. A company with net retention above 110% is expanding faster than it churns, which is the revenue quality profile growth equity investors want to see at the Series B stage.
The Capital Raise Pre-Flight is IRC Partners’ fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership. It is where every engagement begins, whether you are pre-revenue building toward a first institutional round or scaling a company that has raised before. For deals that clear, the full strategic partnership follows. IRC Partners advises operators raising $5M to $250M of institutional capital. If you are taking a raise to market, start here.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of seven
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.